Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section
NCT07661758Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Jul 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in Headache, sponsored by Tanta University. Started Jul 2026; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT07661758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07661758.